Literature DB >> 12089716

Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience.

Michael A Wallot1, Michael Mathot, Magda Janssen, Tanja Hölter, Kilic Paul, Jean Paul Buts, Raymond Reding, Jean Bernard Otte, Etienne M Sokal.   

Abstract

Increasing numbers of children undergo successful liver transplantation. Limited data exist on long-term survival and late graft loss. Survival and graft loss were studied in 376 primary liver graft recipients who survived more than 3 months after transplantation (80.5% of all primary graft recipients). Patient records were reviewed retrospectively for causes of graft loss. Risk factors were identified by analyzing graft, recipient, and posttransplant variables using multivariate Cox regression. One-, 5-, and 10-year actuarial graft survival rates in the study population were 94.6%, 87.3%, and 86.3%, respectively. Corresponding patient survival rates were 95.7%, 91.4%, and 90.4%. Forty-seven (12.5%) grafts were lost subsequently, 15 by patient death with preserved graft function. Survival rate after late retransplantation was 63.3%. Causes of late graft loss were infection (21.2%), posttransplant lymphoproliferative disease (PTLD, 21.2%), chronic rejection (17%), biliary complications (14.8%), and recurrence of malignant disease (8.5%). Independent risk factors for late graft loss and patient death included liver malignancy as primary disease, steroid resistant rejection, and PTLD. Graft loss rate was significantly increased for reduced-size grafts. Patients undergoing transplantation after 1991 and recipients of full-size grafts were more likely to survive. In conclusion, the long-term outcome for pediatric primary liver graft recipients surviving the early postoperative period is excellent except for patients with liver malignancy. There is no increased risk of late graft loss with the use of split or living related donor grafts. Technical complications are only a minor factor in late graft loss, but complications related to immunosuppression and infection remain a major hazard and must be addressed.

Entities:  

Mesh:

Year:  2002        PMID: 12089716     DOI: 10.1053/jlts.2002.34149

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  16 in total

Review 1.  Islet transplant: an option for childhood diabetes?

Authors:  E Hathout; J Lakey; J Shapiro
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation.

Authors:  Yukihiro Sanada; Koshi Matsumoto; Taizen Urahashi; Yoshiyuki Ihara; Taiichi Wakiya; Noriki Okada; Naoya Yamada; Yuta Hirata; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience.

Authors:  Matteo Cescon; Marco Spada; Michele Colledan; Giuliano Torre; Enzo Andorno; Umberto Valente; Giorgio Rossi; Paolo Reggiani; Umberto Cillo; Umberto Baccarani; Gian Luca Grazi; Giuseppe Tisone; Franco Filipponi; Massimo Rossi; Giuseppe Maria Ettorre; Mauro Salizzoni; Oreste Cuomo; Tullia De Feo; Bruno Gridelli
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

4.  School outcomes in children registered in the studies for pediatric liver transplant (SPLIT) consortium.

Authors:  Susan M Gilmour; Lisa G Sorensen; Ravinder Anand; Wanrong Yin; Estella M Alonso
Journal:  Liver Transpl       Date:  2010-09       Impact factor: 5.799

5.  Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases.

Authors:  Robert S Venick; Douglas G Farmer; Sue V McDiarmid; John P Duffy; Sherilyn A Gordon; Hasan Yersiz; Johnny C Hong; Jorge H Vargas; Marvin E Ament; Ronald W Busuttil
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

6.  [Living donation liver transplantation in children].

Authors:  B Dresske; M Schulze; F Braun; J Walter; M Kohl; S Schulz-Jürgensen; M Krause; M Schrappe; M Burdelski; D C Bröring
Journal:  Chirurg       Date:  2010-09       Impact factor: 0.955

7.  Targeting Calcineurin Inhibitor-Induced Arterial Hypertension in Liver Transplanted Children Using Hydrochlorothiazide.

Authors:  Steffen Hartleif; Hannah Baier; Matthias Kumpf; Rupert Handgretinger; Alfred Königsrainer; Silvio Nadalin; Ekkehard Sturm
Journal:  J Pediatr Pharmacol Ther       Date:  2022-07-06

Review 8.  In vitro assays of allosensitization.

Authors:  Udeme D Ekong; Stephen D Miller; Maurice R G O'Gorman
Journal:  Pediatr Transplant       Date:  2008-11-12

Review 9.  Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?

Authors:  Sandy Feng
Journal:  Curr Opin Organ Transplant       Date:  2008-10       Impact factor: 2.640

Review 10.  Outcomes of Technical Variant Liver Transplantation versus Whole Liver Transplantation for Pediatric Patients: A Meta-Analysis.

Authors:  Hui Ye; Qiang Zhao; Yufang Wang; Dongping Wang; Zhouying Zheng; Paul Michael Schroder; Yao Lu; Yuan Kong; Wenhua Liang; Yushu Shang; Zhiyong Guo; Xiaoshun He
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.